European stocks gain, but AstraZeneca slumps

European stocks edge higher Tuesday, with the pan-European benchmark hanging at a six-year high, but AstraZeneca shares are struggling after Pfizer officially walked away from its pursuit of the British drug maker.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.